Nifty
Sensex
:
:
10911.70
35641.46
17.00 (0.16%)
129.88 (0.37%)

Chemicals

Rating :
63/99   (View)

BSE: 530019 | NSE: JUBILANT

887.00
7.05 (0.80%)
22-Jan-2018 | 1:34PM
  • Day's Open
  • Day's High
  • Day's Low
  • Previous Close
  • 884.35
  • 911.90
  • 882.65
  • 879.95
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  • 684005
  • 6067.12
  • 974.00
  • 600.00

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 14,005.59
  • 21.95
  • 1
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 17,591.24
  • 0.34%
  • 3.51

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 54.02%
  • 3.12%
  • 13.8%
  • FII
  • DII
  • Others
  • 0.39%
  • 4.77%
  • 23.90%

Chart

Price | P:E | P:BV | EV:EBITDA

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Dec 17
Dec 16
Var%
Sep 17
Sep 16
Var%
Jun 17
Jun 16
Var%
Mar 17
Mar 16
Var%
Net Sales
2,067.76
1,458.22
41.80%
1,642.04
1,385.50
18.52%
1,596.05
1,419.53
12.44%
1,641.42
1,501.27
9.34%
Expenses
1,650.92
1,126.40
46.57%
1,335.98
1,045.17
27.82%
1,258.44
1,051.37
19.70%
1,336.44
1,183.31
12.94%
EBITDA
416.84
331.82
25.62%
306.06
340.33
-10.07%
337.61
368.16
-8.30%
304.98
317.96
-4.08%
EBIDTM
20.16%
22.25%
18.64%
23.98%
21.15%
25.94%
18.58%
21.18%
Other Income
3.22
5.12
-37.11%
7.09
4.92
44.11%
6.81
4.29
58.74%
10.53
2.52
317.86%
Interest
77.06
98.19
-21.52%
66.01
79.96
-17.45%
68.73
82.77
-16.96%
80.19
89.93
-10.83%
Depreciation
81.82
72.65
12.62%
79.01
72.01
9.72%
72.48
71.52
1.34%
75.22
126.02
-40.31%
PBT
261.18
166.48
56.88%
168.13
193.43
-13.08%
203.21
218.26
-6.90%
160.10
120.99
32.32%
Tax
48.34
47.99
0.73%
42.66
49.72
-14.20%
59.50
54.24
9.70%
11.07
50.31
-78.00%
PAT
212.84
118.49
79.63%
125.47
143.71
-12.69%
143.71
164.02
-12.38%
149.03
70.68
110.85%
PATM
10.29%
7.94%
7.64%
10.13%
9.00%
11.55%
9.08%
4.71%
EPS
13.64
7.69
77.37%
8.24
9.31
-11.49%
9.45
10.14
-6.80%
9.64
4.44
117.12%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Mar 09
Mar 08
Net Sales
6,947.27
5,861.43
5,749.13
5,826.25
5,803.36
5,165.95
4,303.13
3,445.62
3,791.13
3,517.98
2,488.34
Net Sales Growth
20.52%
1.95%
-1.32%
0.39%
12.34%
20.05%
24.89%
-9.11%
7.76%
41.38%
 
Cost Of Goods Sold
2,568.41
2,002.74
2,116.20
2,663.02
2,438.46
2,062.85
1,618.87
1,339.68
1,471.11
1,352.42
986.26
Gross Profit
4,378.86
3,858.69
3,632.94
3,163.23
3,364.90
3,103.10
2,684.26
2,105.95
2,320.02
2,165.57
1,502.08
GP Margin
63.03%
65.83%
63.19%
54.29%
57.98%
60.07%
62.38%
61.12%
61.20%
61.56%
60.36%
Total Expenditure
5,581.78
4,516.14
4,502.19
5,124.71
4,782.37
4,097.81
3,412.94
2,880.76
3,111.07
2,834.73
2,034.35
Power & Fuel Cost
-
333.66
366.71
393.04
389.74
356.73
286.89
224.04
220.03
197.91
170.43
% Of Sales
-
5.69%
6.38%
6.75%
6.72%
6.91%
6.67%
6.50%
5.80%
5.63%
6.85%
Employee Cost
-
1,230.93
1,125.09
1,090.28
1,105.17
962.58
836.36
718.54
735.21
648.49
375.71
% Of Sales
-
21.00%
19.57%
18.71%
19.04%
18.63%
19.44%
20.85%
19.39%
18.43%
15.10%
Manufacturing Exp.
-
428.84
436.46
432.40
405.14
360.48
329.75
284.66
315.90
293.91
230.80
% Of Sales
-
7.32%
7.59%
7.42%
6.98%
6.98%
7.66%
8.26%
8.33%
8.35%
9.28%
General & Admin Exp.
-
280.98
256.23
302.28
264.23
208.35
200.72
195.72
196.68
191.38
137.43
% Of Sales
-
4.79%
4.46%
5.19%
4.55%
4.03%
4.66%
5.68%
5.19%
5.44%
5.52%
Selling & Distn. Exp.
-
185.79
135.54
203.98
160.04
123.28
111.85
90.92
125.97
124.22
107.56
% Of Sales
-
3.17%
2.36%
3.50%
2.76%
2.39%
2.60%
2.64%
3.32%
3.53%
4.32%
Miscellaneous Exp.
-
53.20
65.96
39.72
19.59
23.53
28.50
27.21
46.18
26.41
107.56
% Of Sales
-
0.91%
1.15%
0.68%
0.34%
0.46%
0.66%
0.79%
1.22%
0.75%
1.05%
EBITDA
1,365.49
1,345.29
1,246.94
701.54
1,020.99
1,068.14
890.19
564.86
680.06
683.25
453.99
EBITDA Margin
19.66%
22.95%
21.69%
12.04%
17.59%
20.68%
20.69%
16.39%
17.94%
19.42%
18.24%
Other Income
27.65
24.86
13.37
42.45
19.06
29.87
31.48
17.24
118.09
106.66
144.41
Interest
291.99
341.11
371.35
367.61
337.11
310.93
238.23
119.99
155.57
330.09
38.36
Depreciation
308.53
291.40
346.74
287.95
281.17
253.79
220.65
180.10
124.68
163.24
103.91
PBT
792.62
737.64
542.22
88.43
421.78
533.29
462.79
282.02
517.90
296.58
456.13
Tax
161.57
163.02
155.40
80.48
69.64
152.36
68.41
13.37
95.94
26.72
57.28
Tax Rate
20.38%
22.10%
28.66%
199.55%
33.60%
44.66%
59.95%
5.56%
18.52%
9.01%
12.56%
PAT
631.05
575.66
391.83
-57.76
109.04
152.73
14.56
229.72
421.46
283.18
400.50
PAT before Minority Interest
638.07
574.63
386.82
-40.16
137.64
188.78
45.69
227.23
421.95
269.86
398.85
Minority Interest
7.02
1.03
5.01
-17.60
-28.60
-36.05
-31.13
2.49
-0.49
13.32
1.65
PAT Margin
9.08%
9.82%
6.82%
-0.99%
1.88%
2.96%
0.34%
6.67%
11.12%
8.05%
16.10%
PAT Growth
27.00%
46.92%
778.38%
-152.97%
-28.61%
948.97%
-93.66%
-45.49%
48.83%
-29.29%
 
Unadjusted EPS
40.97
36.93
25.10
-3.63
6.85
9.59
0.91
14.42
28.56
19.22
27.28

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Mar 09
Mar 08
Shareholder's Funds
3,436.04
2,966.26
2,453.52
2,626.51
2,476.12
2,257.03
2,172.27
2,201.34
1,542.64
1,256.20
Share Capital
15.57
15.54
15.93
15.45
15.93
15.93
15.93
15.88
14.76
14.62
Total Reserves
3,420.47
2,950.72
2,437.59
2,611.07
2,460.19
2,241.10
2,156.34
2,185.46
1,527.89
1,241.50
Non-Current Liabilities
3,826.06
3,347.13
4,036.15
2,184.95
3,004.85
3,224.12
3,048.25
3,365.15
4,056.86
2,238.68
Secured Loans
1,207.91
2,620.41
3,316.29
1,716.67
1,708.74
2,839.47
2,435.91
2,160.79
2,966.30
1,058.59
Unsecured Loans
2,297.13
392.79
375.00
0.22
760.06
0.45
400.61
1,011.94
975.49
1,049.87
Long Term Provisions
80.69
70.31
67.04
219.53
237.96
169.70
39.87
0.00
0.00
0.00
Current Liabilities
1,675.94
2,464.44
2,129.16
3,894.41
2,778.35
2,212.79
2,269.67
1,220.11
1,130.63
667.91
Trade Payables
749.49
612.12
721.19
718.14
647.13
836.98
517.43
688.83
584.06
306.65
Other Current Liabilities
572.70
951.43
793.31
1,731.20
898.00
499.55
465.94
64.70
88.72
65.14
Short Term Borrowings
255.60
748.97
517.17
1,187.83
1,131.39
767.07
883.03
0.00
0.00
0.00
Short Term Provisions
98.14
151.93
97.49
257.25
101.84
109.18
403.28
466.59
457.85
296.13
Total Liabilities
8,898.75
8,739.70
8,618.83
8,863.81
8,370.86
7,762.89
7,532.00
6,824.52
6,762.08
4,184.18
Net Block
5,106.73
5,104.42
4,911.33
5,098.78
4,967.46
4,460.18
3,991.05
3,818.89
3,745.00
1,912.42
Gross Block
5,672.38
5,390.82
7,362.10
7,330.63
6,870.15
6,084.09
5,163.28
4,845.26
4,648.26
2,495.91
Accumulated Depreciation
565.66
286.40
2,450.76
2,231.85
1,902.69
1,623.92
1,172.22
1,026.38
903.26
583.49
Non Current Assets
5,950.63
5,864.37
5,904.29
5,935.78
5,809.80
5,465.57
4,940.25
4,357.21
4,281.34
2,402.01
Capital Work in Progress
683.78
611.32
596.60
472.39
436.89
685.55
666.71
505.63
503.12
484.69
Non Current Investment
102.71
85.43
39.50
33.99
25.61
19.20
32.75
32.70
33.22
4.90
Long Term Loans & Adv.
56.32
62.67
327.17
328.42
379.47
299.86
249.18
0.00
0.00
0.00
Other Non Current Assets
1.08
0.53
29.68
2.21
0.37
0.79
0.55
0.00
0.00
0.00
Current Assets
2,948.12
2,875.32
2,714.54
2,928.03
2,561.06
2,297.32
2,591.75
2,455.22
2,205.31
1,780.52
Current Investments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
223.71
238.13
40.73
Inventories
1,220.40
1,203.10
1,235.33
1,341.42
1,116.18
1,020.22
691.28
690.95
595.61
434.97
Sundry Debtors
1,005.30
950.50
819.27
805.87
708.54
652.69
520.45
518.61
504.41
425.78
Cash & Bank
459.63
344.58
394.34
479.53
356.05
266.82
1,045.14
503.67
381.66
523.77
Other Current Assets
262.79
244.07
121.03
165.17
380.29
357.59
334.88
518.27
485.49
355.27
Short Term Loans & Adv.
37.06
133.06
144.56
136.04
182.01
256.70
217.50
498.14
444.09
323.54
Net Current Assets
1,272.18
410.88
585.38
-966.38
-217.29
84.53
322.08
1,235.11
1,074.69
1,112.61
Total Assets
8,898.75
8,739.69
8,618.83
8,863.81
8,370.86
7,762.89
7,532.00
6,824.51
6,762.08
4,184.18

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Mar 09
Mar 08
Cash From Operating Activity
1,268.49
1,098.89
783.26
772.27
969.90
707.17
389.75
709.61
558.06
257.47
PBT
737.64
542.22
40.32
207.28
341.14
114.11
240.59
517.90
296.58
456.13
Adjustment
637.90
737.89
725.84
756.60
752.36
795.44
318.42
189.22
352.94
34.70
Changes in Working Capital
36.88
-133.16
96.40
-110.70
-4.04
-136.91
-84.14
62.58
-55.56
-185.10
Cash after chg. in Working capital
1,412.42
1,146.96
862.57
853.18
1,089.46
772.64
474.88
769.70
593.96
305.73
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-143.94
-48.07
-79.31
-80.91
-119.56
-65.47
-85.14
-60.57
-41.99
-45.42
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-450.39
-312.53
-343.33
-174.42
-499.72
-594.31
-352.15
-279.75
-2,030.73
-1,139.35
Net Fixed Assets
-115.33
785.60
1,162.43
-166.96
-286.05
-434.15
-275.33
-128.63
-492.68
-281.91
Net Investments
-0.39
57.01
239.81
-27.56
-18.79
-95.66
5.14
-159.67
-331.27
-102.45
Others
-334.67
-1,155.14
-1,745.57
20.10
-194.88
-64.50
-81.96
8.55
-1,206.78
-754.99
Cash from Financing Activity
-685.87
-842.75
-502.69
-414.41
-449.76
-888.82
608.21
-298.02
1,150.66
592.81
Net Cash Inflow / Outflow
132.22
-56.38
-62.76
183.44
20.41
-775.95
645.81
131.84
-322.01
-289.08
Opening Cash & Equivalents
339.27
391.64
473.49
279.65
263.08
1,041.15
498.27
381.66
523.77
874.91
Closing Cash & Equivalent
456.44
339.27
391.63
473.49
279.65
263.08
1,041.15
505.34
375.89
523.82

Financial Ratios

Consolidated /

Standalone
Description
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Mar 09
Mar 08
Book Value (Rs.)
220.64
190.90
154.04
170.07
155.46
141.70
136.38
137.88
85.89
85.81
ROA
6.52%
4.46%
-0.46%
1.60%
2.34%
0.60%
3.17%
6.21%
4.93%
10.75%
ROE
17.95%
14.27%
-1.58%
5.39%
7.98%
2.06%
10.42%
24.42%
21.40%
36.99%
ROCE
14.44%
12.42%
5.72%
7.92%
10.19%
5.79%
6.29%
12.74%
14.62%
16.71%
Fixed Asset Turnover
1.09
0.92
0.81
0.84
0.82
0.78
0.70
0.82
1.02
1.26
Receivable days
59.43
54.81
49.56
46.53
47.00
48.71
53.83
48.18
46.63
50.03
Inventory Days
73.64
75.51
78.58
75.51
73.76
71.07
71.61
60.59
51.66
54.72
Payable days
54.84
53.44
52.17
51.42
45.33
38.70
50.95
58.42
49.77
49.78
Cash Conversion Cycle
78.23
76.88
75.98
70.61
75.42
81.08
74.50
50.34
48.52
54.97
Total Debt/Equity
1.18
1.51
1.95
1.67
1.71
1.69
1.81
1.45
3.11
1.68
Interest Cover
3.16
2.46
1.11
1.61
2.10
1.48
3.01
4.33
1.90
12.89

News Update


  • Jubilant Life Sciences issues CPs worth Rs 90 crore
    18th Jan 2018, 09:44 AM

    The company has issued the papers on January 17, 2018

    Read More
  • Jubilant LifeScience - Quarterly Results
    17th Jan 2018, 14:32 PM

    Read More
  • Jubilant Life Sciences receives EC for Rs 250 crore pesticide project
    15th Jan 2018, 09:49 AM

    The proposal is to set up a technical grade pesticide and pesticide-specific intermediate manufacturing facilities having a total production capacity of 32,350 tonnes per annum

    Read More
  • Jubilant receives USFDA approval for Draximage DTPA
    28th Dec 2017, 15:26 PM

    Draximage DTPA is a kit for the preparation of Technetium Tc99m pentetate injection

    Read More
  • Jubilant Life Sciences gets Green panel’s approval for pesticide project
    4th Dec 2017, 10:48 AM

    The proposed unit will be set up in an area of 20 hectare in Vagra taluk of Bharuch district

    Read More
  • Jubilant Life Sciences' arm enters into stock purchase agreement
    23rd Nov 2017, 10:29 AM

    After the said acquisition of shares, JDSI shall become a wholly-owned subsidiary of DDDSL

    Read More
  • Jubilant Life Sciences issues commercial papers worth Rs 50 crore
    4th Nov 2017, 10:55 AM

    The aggregate amount of commercial papers outstanding as on date is Rs 100 crore

    Read More
  • Jubilant Life Sciences issues commercial papers worth Rs 50 crore
    18th Oct 2017, 11:13 AM

    The company has issued two commercial papers of Rs 25 crore each providing an interest rate of 6.50% p.a. and 6.48% p.a.

    Read More

Source: www.accordfintech.com. Price feed provided by www.nseindia.com and www.bseindia.com value addition by www.accordfintech.com. Intraday data delayed 15 minutes.

DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.